Literature DB >> 21528474

Hormonal abnormalities in first-degree relatives of women with polycystic ovary syndrome (PCOS).

Agnieszka Lenarcik1, Bożena Bidzińska-Speichert, Urszula Tworowska-Bardzińska, Katarzyna Krępuła.   

Abstract

INTRODUCTION: A body of evidence points to a familial aggregation of hormonal abnormalities in first-degree relatives of women with polycystic ovary syndrome (PCOS). The aim of this study was to determine whether siblings of women with PCOS had evidence of hormonal abnormalities typical of PCOS.
MATERIAL AND METHODS: Eighty-six siblings of women with PCOS (44 sisters, 42 brothers) were recruited. Two control groups consisted of 70 healthy women and 30 healthy men. Anthropometric, hormonal (testosterone, androstenedione, DHEA-S, LH, FSH) parameters and SHBG were assessed in all subjects.
RESULTS: Mean testosterone and DHEA-S levels were higher in sisters of women with PCOS than in the control women. In eight of the 44 (18.2%) sisters, a diagnosis of PCOS was made. Mean testosterone and androstenedione levels, and free androgen index (FAI) were significantly higher in sisters with PCOS compared to the sisters without PCOS. Brothers of women with PCOS had higher DHEA-S level than the control men. Eleven of the 42 (26.2%) brothers had alopecia occurring before the age of 30. Prematurely balding brothers did not differ from the non-balding brothers in hormonal parameters.
CONCLUSIONS: Siblings of women with PCOS are predisposed to hormonal abnormalities typical of PCOS. The symptom of premature balding under the age of 30 in brothers of women with PCOS should not be considered as a male PCOS equivalent.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21528474

Source DB:  PubMed          Journal:  Endokrynol Pol        ISSN: 0423-104X            Impact factor:   1.582


  7 in total

Review 1.  Does a male polycystic ovarian syndrome equivalent exist?

Authors:  R Cannarella; R A Condorelli; L M Mongioì; S La Vignera; A E Calogero
Journal:  J Endocrinol Invest       Date:  2017-07-15       Impact factor: 4.256

2.  PCOS - a metabolic condition with health impacts on women and men.

Authors:  Anju E Joham; Helena J Teede
Journal:  Nat Rev Endocrinol       Date:  2022-04       Impact factor: 43.330

Review 3.  Metabolic syndrome, hypertension, and hyperlipidemia in mothers, fathers, sisters, and brothers of women with polycystic ovary syndrome: a systematic review and meta-analysis.

Authors:  Bulent Yilmaz; Priyathama Vellanki; Baris Ata; Bulent Okan Yildiz
Journal:  Fertil Steril       Date:  2018-01-11       Impact factor: 7.329

4.  MIF May Participate in Pathogenesis of Polycystic Ovary Syndrome in Rats through MAPK Signalling Pathway.

Authors:  Dan-Ni Zhou; Sai-Jiao Li; Jin-Li Ding; Tai-Lang Yin; Jing Yang; Hong Ye
Journal:  Curr Med Sci       Date:  2018-10-20

5.  Altered glucose disposition and insulin sensitivity in peri-pubertal first-degree relatives of women with polycystic ovary syndrome.

Authors:  Nouhad Raissouni; Andrey Kolesnikov; Radhika Purushothaman; Sunil Sinha; Sonal Bhandari; Amrit Bhangoo; Shahid Malik; Revi Mathew; Jean-Patrice Baillargeon; Maria Isabel Hernandez; Michael Rosenbaum; Svetlana Ten; David Geller
Journal:  Int J Pediatr Endocrinol       Date:  2012-05-29

Review 6.  Fundamental Concepts and Novel Aspects of Polycystic Ovarian Syndrome: Expert Consensus Resolutions.

Authors:  Antonio Aversa; Sandro La Vignera; Rocco Rago; Alessandra Gambineri; Rossella E Nappi; Aldo E Calogero; Alberto Ferlin
Journal:  Front Endocrinol (Lausanne)       Date:  2020-08-11       Impact factor: 5.555

Review 7.  Endocrinology of the Aging Prostate: Current Concepts.

Authors:  Rossella Cannarella; Rosita A Condorelli; Federica Barbagallo; Sandro La Vignera; Aldo E Calogero
Journal:  Front Endocrinol (Lausanne)       Date:  2021-02-22       Impact factor: 5.555

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.